This research explores the feasibility of hybrid treatment planning for breast and esophageal cancer in high-volume radiotherapy centers.
Comparison of hybrid planning to IMRT in terms of planning time and organ at risk (OAR) doses.
Assessment of patient outcomes in high-patient-volume settings.
Hybrid planning shows comparable planning time to IMRT.
Hybrid planning provides reduced OAR doses compared to traditional methods.
Abstract
Considering its comparable planning time to IMRT and the added benefit of reduced OAR doses, hybrid planning could be a valuable option in high-patient-volume settings.